메뉴 건너뛰기




Volumn 28, Issue 2, 2005, Pages 254-258

Recombinant activated factor VII in the management of life-threatening bleeding in cardiac surgery

Author keywords

Cardiac surgery; Life threatening bleeding; Recombinant activated factor VII

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

EID: 22544446183     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2005.04.021     Document Type: Review
Times cited : (47)

References (25)
  • 2
    • 0035163406 scopus 로고    scopus 로고
    • Mechanisms and attenuation of hemostatic activation during extracorporeal circulation
    • G.J. Despotis, M.S. Avidan, and C.W. Hogue Jr Mechanisms and attenuation of hemostatic activation during extracorporeal circulation Ann Thorac Surg 72 2001 S1821 S1831
    • (2001) Ann Thorac Surg , vol.72
    • Despotis, G.J.1    Avidan, M.S.2    Hogue Jr., C.W.3
  • 3
    • 4444229924 scopus 로고    scopus 로고
    • Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial
    • K.A. Fox, S.R. Mehta, R. Peters, F. Zhao, N. Lakkis, B.J. Gersh, and S. Yusuf Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial Circulation 110 2004 1202 1208
    • (2004) Circulation , vol.110 , pp. 1202-1208
    • Fox, K.A.1    Mehta, S.R.2    Peters, R.3    Zhao, F.4    Lakkis, N.5    Gersh, B.J.6    Yusuf, S.7
  • 5
    • 0036363842 scopus 로고    scopus 로고
    • Potential role for rFVIIa in transfusion medicine
    • U. Hedner, and E. Erhardtsen Potential role for rFVIIa in transfusion medicine Transfusion 42 2002 114 124
    • (2002) Transfusion , vol.42 , pp. 114-124
    • Hedner, U.1    Erhardtsen, E.2
  • 6
    • 0031788228 scopus 로고    scopus 로고
    • Recombinant activated factor VII as a universal haemostatic agent
    • U. Hedner Recombinant activated factor VII as a universal haemostatic agent Blood Coagul Fibrinolysis 9 1998 S147 S152
    • (1998) Blood Coagul Fibrinolysis , vol.9
    • Hedner, U.1
  • 7
    • 0033610715 scopus 로고    scopus 로고
    • Treatment of traumatic bleeding with recombinant factor VIIa
    • G. Kenet, R. Walden, A. Eldad, and U. Martinowitz Treatment of traumatic bleeding with recombinant factor VIIa Lancet 354 1999 1879
    • (1999) Lancet , vol.354 , pp. 1879
    • Kenet, G.1    Walden, R.2    Eldad, A.3    Martinowitz, U.4
  • 9
    • 0034914327 scopus 로고    scopus 로고
    • An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII
    • H.G. Hendriks, J.M. van der Maaten, J. de Wolf, T.W. Waterbolk, M.J. Slooff, and J. van der Meer An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII Anesth Analg 93 2001 287 289
    • (2001) Anesth Analg , vol.93 , pp. 287-289
    • Hendriks, H.G.1    Van Der Maaten, J.M.2    De Wolf, J.3    Waterbolk, T.W.4    Slooff, M.J.5    Van Der Meer, J.6
  • 10
  • 11
    • 0042925371 scopus 로고    scopus 로고
    • Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass
    • V.N. Naik, C.D. Mazer, D.A. Latter, J.M. Teitel, and G.M. Hare Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass Can J Anaesth 50 2003 599 602
    • (2003) Can J Anaesth , vol.50 , pp. 599-602
    • Naik, V.N.1    Mazer, C.D.2    Latter, D.A.3    Teitel, J.M.4    Hare, G.M.5
  • 12
    • 0036795428 scopus 로고    scopus 로고
    • Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery
    • C. von Heymann, H. Hotz, W. Konertz, W.J. Kox, and C. Spies Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass graft surgery J Cardiothorac Vasc Anesth 16 2002 615 616
    • (2002) J Cardiothorac Vasc Anesth , vol.16 , pp. 615-616
    • Von Heymann, C.1    Hotz, H.2    Konertz, W.3    Kox, W.J.4    Spies, C.5
  • 13
    • 19444374002 scopus 로고    scopus 로고
    • Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
    • A. Aggarwal, V. Malkovska, J.P. Catlett, and K. Alcorn Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage Thromb J 2 2004 9
    • (2004) Thromb J , vol.2 , pp. 9
    • Aggarwal, A.1    Malkovska, V.2    Catlett, J.P.3    Alcorn, K.4
  • 14
    • 0028933865 scopus 로고
    • Hemostatic complications of cardiopulmonary bypass
    • R.W. Colman Hemostatic complications of cardiopulmonary bypass Am J Hematol 48 1995 267 272
    • (1995) Am J Hematol , vol.48 , pp. 267-272
    • Colman, R.W.1
  • 15
    • 0038375322 scopus 로고    scopus 로고
    • The management of perioperative bleeding
    • M.B. Koh, and B.J. Hunt The management of perioperative bleeding Blood Rev 17 2003 179 185
    • (2003) Blood Rev , vol.17 , pp. 179-185
    • Koh, M.B.1    Hunt, B.J.2
  • 16
    • 3242803508 scopus 로고    scopus 로고
    • Reexploration for bleeding after coronary artery bypass surgery: Risk factors, outcomes, and the effect of time delay
    • S. Karthik, A.D. Grayson, E.E. McCarron, D.M. Pullan, and M.J. Desmond Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay Ann Thorac Surg 78 2004 527 534
    • (2004) Ann Thorac Surg , vol.78 , pp. 527-534
    • Karthik, S.1    Grayson, A.D.2    McCarron, E.E.3    Pullan, D.M.4    Desmond, M.J.5
  • 17
    • 0242267415 scopus 로고    scopus 로고
    • Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: A review
    • M. Grounds Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review Blood Rev 17 2003 S11 S21
    • (2003) Blood Rev , vol.17
    • Grounds, M.1
  • 18
    • 3442877919 scopus 로고    scopus 로고
    • Recombinant activated factor VII (NovoSeven): Addition to replacement therapy in acute, uncontrolled and life-threatening bleeding
    • A. Mayo, M. Misgav, Y. Kluger, R. Geenberg, D. Pauzner, J. Klausner, and O. Ben-Tal Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding Vox Sang 87 2004 34 40
    • (2004) Vox Sang , vol.87 , pp. 34-40
    • Mayo, A.1    Misgav, M.2    Kluger, Y.3    Geenberg, R.4    Pauzner, D.5    Klausner, J.6    Ben-Tal, O.7
  • 19
    • 0348163468 scopus 로고    scopus 로고
    • The effect of temperature and pH on the activity of factor VIIa: Implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients
    • Z.H. Meng, A.S. Wolberg, D.M. Monroe 3rd, and M. Hoffman The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients J Trauma 55 2003 886 891
    • (2003) J Trauma , vol.55 , pp. 886-891
    • Meng, Z.H.1    Wolberg, A.S.2    Monroe III, D.M.3    Hoffman, M.4
  • 20
    • 0036241743 scopus 로고    scopus 로고
    • Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery
    • W. Dietrich, and M. Spannagl Caveat against the use of activated recombinant factor VII for intractable bleeding in cardiac surgery Anesth Analg 94 2002 1369 1370
    • (2002) Anesth Analg , vol.94 , pp. 1369-1370
    • Dietrich, W.1    Spannagl, M.2
  • 22
    • 3042651670 scopus 로고    scopus 로고
    • Recombinant factor VIIa for life-threatening bleeding in high-risk cardiac surgery despite full-dose aprotinin
    • D.R. McIlroy, and A.J. Silvers Recombinant factor VIIa for life-threatening bleeding in high-risk cardiac surgery despite full-dose aprotinin Anesth Analg 99 2004 27 30
    • (2004) Anesth Analg , vol.99 , pp. 27-30
    • McIlroy, D.R.1    Silvers, A.J.2
  • 24
    • 19044372377 scopus 로고    scopus 로고
    • To general haemostasis-the evidence-based route
    • E. Erhardtsen To general haemostasis-the evidence-based route Pathophysiol Haemost Thromb 32 2002 47 52
    • (2002) Pathophysiol Haemost Thromb , vol.32 , pp. 47-52
    • Erhardtsen, E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.